COVID-19
Pharmafile.com’s weekly COVID-19 news round-up
March 24, 2021Research and Development COVID-19, covid 19 news, covid-19 news, news roundup
The past week has seen plenty of positive COVID-19 news; the Oxford-AstraZeneca vaccine was deemed safe and effective by the …
Roche’s drug cocktail reduces hospitalisation due to COVID-19 in Phase III trial
March 24, 2021Research and Development COVID-19, Roche, covid-19 treatment
Roche’s antibody drug combination of casirivimab and imdevimab has shown to reduce hospitalisation or death by 70% in non-hospitalised patients …
Daiichi Sankyo begins trial for mRNA COVID-19 vaccine in Japan
March 22, 2021Sales and Marketing COVID-19, Vaccine
Daiichi Sankyo, a global pharmaceutical company that provides services in 20 countries worldwide, has announced the first vaccinations as part …
Pharmafile.com’s top 10 news stories of the week
March 19, 2021Medical Communications COVID, COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news
In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been …
RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine
March 19, 2021Medical Communications COVID-19, Russia, Vaccine
The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply …
AstraZeneca COVID-19 vaccine deemed “safe and effective” by EMA
March 19, 2021Medical Communications AstraZeneca, COVID-19, EMA, Vaccine
AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 …
Florida woman gives birth to first-known baby born with COVID-19 antibodies
March 18, 2021COVID-19, Moderna, Vaccine
A woman from Florida has given birth to the first-known baby born with COVID-19 antibodies, according to findings recently published …
Pharmafile.com’s weekly COVID-19 news round-up
March 17, 2021Research and Development COVID-19, covid-19 roundup, news roundup
The past week has seen a mix of good and bad COVID-19 news; the Oxford-AstraZeneca vaccine rollout has halted throughout …
Medicago & GSK start plant-derived COVID-19 vaccine trial
March 17, 2021Research and Development COVID-19, GSK
Medicago and GSK have announced the start of Phase III clinical testing of Medicago’s plant-derived COVID-19 vaccine. The vaccine candidate …
Netherlands suspends AstraZeneca vaccine despite safety assurances
March 15, 2021Medical Communications, Sales and Marketing AstraZeneca, COVID-19, EMA, EU, WHO
The Netherlands has become the latest country to suspend the use of the Oxford-AstraZeneca vaccine amid concerns it may cause …
Pharmafile.com’s top 10 news stories of the week
March 12, 2021Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma news
In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody …
Kintor’s COVID-19 treatment reduces mortality by 92%
March 12, 2021Medical Communications Brazil, Brazil variant, COVID-19, Kintor, covid-19 treatment
Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial …
J&J’s one-shot COVID-19 vaccine approved by European Commission
March 12, 2021Medical Communications COVID-19, EMA, Johnson & Johnson
The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced on Thursday. …
Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains
March 12, 2021Medical Communications COVID-19, Novavax, vaccines
Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …
Altimmune expands COVID-19 vaccine manufacturing deal with Lonza
March 12, 2021Medical Communications Altimmune, COVID-19, Lonza, vaccines
Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
